ConductScience.org, home

Paper36836166

Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy.

Leone GM and 4 others. J Clin Med, 2023. Cited by 147 papers, by iCite.

Cite this record

ConductScience Library. Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy. Papers, record 36836166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36836166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy.
PubMed
Journal
J Clin Med
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
147
iCite
Relative citation ratio, by iCite
16.4
iCite
Revised in PubMed
2023-03-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leone GMGian Marco
2Mangano KKatiahttps://orcid.org/0000-0001-5920-4620
3Petralia MCMaria Cristinahttps://orcid.org/0000-0002-9643-1045
4Nicoletti FFerdinandohttps://orcid.org/0000-0002-4570-8462
5Fagone PPaolohttps://orcid.org/0000-0002-6694-1992

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References191

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134594000The blood-brain barrier in systemic infection and inflammation.Cell Mol Immunol2021https://conductscience.org/library/papers/34594000PubMed
217636564Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents.Inflamm Bowel Dis2007https://conductscience.org/library/papers/17636564PubMed
325624856Tumor necrosis factor inhibitors - state of knowledge.Arch Med Sci2014https://conductscience.org/library/papers/25624856PubMed
428983798Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience.Adv Ther2017https://conductscience.org/library/papers/28983798PubMed
59836088Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference.Inflamm Bowel Dis1998https://conductscience.org/library/papers/9836088PubMed
632682491Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.Lancet2020https://conductscience.org/library/papers/32682491PubMed
731892912Etiology and Management of Lack or Loss of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease.Gastroenterol Hepatol (N Y)2019https://conductscience.org/library/papers/31892912PubMed
812894133Etanercept: An overview.J Am Acad Dermatol2003https://conductscience.org/library/papers/12894133PubMed
934937767Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis.Gut2021https://conductscience.org/library/papers/34937767PubMed
1035817469Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients' offspring.Ann Rheum Dis2022https://conductscience.org/library/papers/35817469PubMed
1115673801Etanercept plus standard therapy for Wegener's granulomatosis.N Engl J Med2005https://conductscience.org/library/papers/15673801PubMed
1231173761Considerations for the Design of Antibody-Based Therapeutics.J Pharm Sci2020https://conductscience.org/library/papers/31173761PubMed
1320694021Research and development of next generation of antibody-based therapeutics.Acta Pharmacol Sin2010https://conductscience.org/library/papers/20694021PubMed
1424092417Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials.Ann Rheum Dis2015https://conductscience.org/library/papers/24092417PubMed
158502296Naturally occurring antibodies devoid of light chains.Nature1993https://conductscience.org/library/papers/8502296PubMed
161172191Continuous cultures of fused cells secreting antibody of predefined specificity.Nature1975https://conductscience.org/library/papers/1172191PubMed
1731744825
Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al.
Ann Rheum Dis2021https://conductscience.org/library/papers/31744825PubMed
1830539472Humanization and Simultaneous Optimization of Monoclonal Antibody.Methods Mol Biol2019https://conductscience.org/library/papers/30539472PubMed
19224739172012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.Arthritis Care Res (Hoboken)2012https://conductscience.org/library/papers/22473917PubMed
2035663580Neuroinflammation: A Possible Link Between Chronic Vascular Disorders and Neurodegenerative Diseases.Front Aging Neurosci2022https://conductscience.org/library/papers/35663580PubMed

See all 191 referencesDownload CSV of references

Cited by103

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 147 citations.

PMIDTitleJournalYearIn PapersSource
42943631Akkermansia Muciniphila Attenuates TNF-α-Induced Injury in Human Primary Colonic Epithelial Cells with Ferroptosis-Associated Redox Remodeling.Microorganisms2026https://conductscience.org/library/papers/42943631PubMed
42851938Immunometabolic programming of macrophages and tumor-associated macrophages: metabolic pathways shaping polarization, immune regulation, and disease outcomes.Front Immunol2026https://conductscience.org/library/papers/42851938PubMed
42771292Compound Kushen Injection Alleviates Experimental Colitis in Mice by Regulating Macrophage Polarization through TLR4/NF-κB Signaling.Chin J Integr Med2026https://conductscience.org/library/papers/42771292PubMed
42769547Advances in tumor necrosis factor-α inhibitors for the treatment of juvenile idiopathic arthritis-associated uveitis.Front Immunol2026https://conductscience.org/library/papers/42769547PubMed
42730326Neuroimmune Interactions in Inflammatory Skin and Intestinal Diseases.J Inflamm Res2026https://conductscience.org/library/papers/42730326PubMed
42638887Glucolipid metabolic dysfunction in ankylosing spondylitis: inflammatory mechanisms, immune-metabolic crosstalk and therapeutic implications of natural products and traditional Chinese medicine.Front Immunol2026https://conductscience.org/library/papers/42638887PubMed
42592597A reproducible pretreatment mucosal-inflammatory-remodeling state is associated with induction-phase anti-tumor necrosis factor non-response in ulcerative colitis.Front Genet2026https://conductscience.org/library/papers/42592597PubMed
42589362The Redox-Inflammation Axis in Atherosclerosis and Ischemic Stroke: Mechanisms, Biomarkers, and Translational Challenges.Int J Mol Sci2026https://conductscience.org/library/papers/42589362PubMed
42461320Integrated Necroptosis Within Programmed Cell Death in Traumatic Brain Injury.Mol Neurobiol2026https://conductscience.org/library/papers/42461320PubMed
42303792Biologic immunomodulators and spinal fusion: evidence, mechanisms, and perioperative considerations.Eur Spine J2026https://conductscience.org/library/papers/42303792PubMed
42131412Tumor necrosis factor-alpha-mediated inflammatory bone loss: Pathogenic mechanisms and therapeutic potential of its inhibitors.Tzu Chi Med J2026https://conductscience.org/library/papers/42131412PubMed
42110595The importance of TNF-α signaling: a potential risk factor in neurodegenerative and cardiovascular diseases.Arch Med Sci2026https://conductscience.org/library/papers/42110595PubMed
41931245Evaluation of the efficacy of various hepatitis B dosage regimens in spondyloarthritis patients undergoing immunomodulatory treatment.Clin Rheumatol2026https://conductscience.org/library/papers/41931245PubMed
41908154Promising TNF-α inhibitors: Targeting pathogenic TNF-α/TNFR signaling to restore Th17/Treg balance in rheumatoid arthritis.J Pharm Anal2026https://conductscience.org/library/papers/41908154PubMed
41832732Rheumatoid Arthritis Management: Emerging Drug Therapies and Innovations.Curr Drug Targets2026https://conductscience.org/library/papers/41832732PubMed
41822736The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis.Front Gastroenterol (Lausanne)2024https://conductscience.org/library/papers/41822736PubMed
41809609Adalimumab Therapy for Crohn's Disease and Axial Spondyloarthritis in Latent Tuberculosis: A bibliometric-systematic literature review.Sultan Qaboos Univ Med J2026https://conductscience.org/library/papers/41809609PubMed
41640516Co-occurrence of Vogt-Koyanagi-Harada disease, diabetic retinopathy, and advanced chronic kidney disease: a case report.Front Med (Lausanne)2026https://conductscience.org/library/papers/41640516PubMed
41632348A comprehensive analysis of epigenetic mechanisms regulating inflammation-induced TNF-α gene expression by small-molecule inhibitor screening.Mol Biol Rep2026https://conductscience.org/library/papers/41632348PubMed
41611908TWEAK receptor (Fn14) exacerbates TNF-α-induced inflammation in rheumatoid arthritis synovial fibroblasts and influences response to anti-TNF-α therapy.Cell Mol Immunol2026https://conductscience.org/library/papers/41611908PubMed

See all 103 cited byDownload CSV of cited by

Genes47

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE259272PubTator's text mininghttps://conductscience.org/library/genes/59272NCBI Gene
ADAM176868PubTator's text mininghttps://conductscience.org/library/genes/6868NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
BIRC3330PubTator's text mininghttps://conductscience.org/library/genes/330NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CASP8841PubTator's text mininghttps://conductscience.org/library/genes/841NCBI Gene
CCL76354PubTator's text mininghttps://conductscience.org/library/genes/6354NCBI Gene
CCR2729230PubTator's text mininghttps://conductscience.org/library/genes/729230NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
HLA-DQA13117PubTator's text mininghttps://conductscience.org/library/genes/3117NCBI Gene
ICAM13383PubTator's text mininghttps://conductscience.org/library/genes/3383NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL1A3552PubTator's text mininghttps://conductscience.org/library/genes/3552NCBI Gene
IL1B3553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene

See all 47 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36836166

GET https://conductscience.org/api/papers/v1/36836166/references?page=2